Literature DB >> 26391406

Pharmaceutical quantities of yohimbine found in dietary supplements in the USA.

Pieter A Cohen1,2, Yan-Hong Wang3, Gregory Maller4, Renan DeSouza4, Ikhlas A Khan3.   

Abstract

In the USA, botanical dietary supplements are presumed to be safe, but this is not necessarily always the case. Extracts of the evergreen tree yohimbe, Pausinystalia johimbe, though banned in many countries, are sold in hundreds of dietary supplements in the USA. We analyzed 49 brands of supplements labelled as containing yohimbe or yohimbine available for sale from seven major retailers in the USA. Supplements were analyzed using ultra high-performance liquid chromatography coupled to photodiode and quadrupole time-of-flight mass spectrometry detectors for quantity of three alkaloids found in P. johimbe (yohimbine, rauwolscine, and corynanthine). The alkaloids were confirmed on the basis of retention time, ultraviolet spectra, and mass spectra against reference standards. The quantity of the most active alkaloid, yohimbine, per recommended serving ranged from none detected to 12.1 mg. Thirty-nine percent of the supplements (19/49) did not contain rauwolscine and corynanthine suggesting that the yohimbine was either from highly processed plant extract or synthetic in origin. Only 11 supplement brands (22%, 11/49) listed a specific quantity of yohimbine on the label. Most of these were inaccurately labelled (actual content ranged from 23% to 147% of the content on the label). Eighteen percent (9/49) of the supplements' labels did not provide any information about yohimbine's adverse effects. Of the 49 yohimbine supplement brands sold at seven major retail chains in the USA, only 4.1% (2/49) provided consumers with both accurate information about the quantity of yohimbine as well as information about yohimbine's known adverse effects.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  corynanthine; dietary supplements; rauwolscine; yohimbine

Mesh:

Substances:

Year:  2015        PMID: 26391406     DOI: 10.1002/dta.1849

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  4 in total

1.  Indole alkaloids as potential candidates against COVID-19: an in silico study.

Authors:  Mehran Mohseni; Hamed Bahrami; Bahman Farajmand; Faezeh Sadat Hosseini; Massoud Amanlou; Hafezeh Salehabadi
Journal:  J Mol Model       Date:  2022-05-11       Impact factor: 2.172

2.  Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance.

Authors:  Megan E Barnes; Camryn R Cowan; Lauren E Boag; Julianne G Hill; Morgan L Jones; Kylie M Nixon; Mckenzie G Parker; Shelby K Parker; Mary V Raymond; Lillie H Sternenberg; Shelby L Tidwell; Taylor M Yount; Tyler D Williams; Rebecca R Rogers; Christopher G Ballmann
Journal:  Int J Environ Res Public Health       Date:  2022-01-25       Impact factor: 3.390

3.  Analysis of Select Dietary Supplement Products Marketed to Support or Boost the Immune System.

Authors:  Cindy Crawford; Bharathi Avula; Andrea T Lindsey; Abraham Walter; Kumar Katragunta; Ikhlas A Khan; Patricia A Deuster
Journal:  JAMA Netw Open       Date:  2022-08-01

4.  Multi-Class Determination of 64 Illicit Compounds in Dietary Supplements Using Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Dasom Shin; Hui-Seung Kang; Hyungsoo Kim; Guiim Moon
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.